Effect of CAFfeine on Cognition in Alzheimer's Disease

NCT04570085 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

248

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Caffeine
DRUG: Placebo

Sponsor

University Hospital, Lille

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]